Inferra AIResearch Tools

Inferra AI / Company / XENE

Xenon Pharmaceuticals

XENE · Health Care

Last earnings Aug 6, 2026

AI analysis

Q2 2026 · reported Aug 6, 2026

Based on: Earnings release + parent 8-K — transcript not held

No extracted figures held

The event-summary record for this company carries no extracted figures, so the brief and charts cannot be drawn yet. The summary below and the held documents are the record for this event.

Guidance · company-stated

No guidance located in the held release

Next earningsNo verified date on fileNo date is estimated or imported
General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Xenon Pharmaceuticals — Earnings release (2026-08-06)

Based on: Earnings release + parent 8-K — transcript not held

Guidance & outlook

No guidance located in the held release

Strategy & priorities

“We also remain focused on broadening azetukalner’s opportunity to neuropsychiatry and expect topline Phase 3 X-NOVA2 data in the first half of 2027.

SEC original ↗Xenon Pharmaceuticals — Earnings release (8-K exhibit)EX-99Aug 6, 2026

Risks & headwinds

These forward-looking statements are based on current assumptions that involve risks, uncertainties and other factors that may cause the actual results, events, or developments to be materially different from those expressed or implied by such forward-looking statements.

SEC original ↗Xenon Pharmaceuticals — Earnings release (8-K exhibit)EX-99Aug 6, 2026

Documents

Earnings deck slides

0 decks with slide view

Xenon Pharmaceuticals — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Gilead Sciences (GILD) Health CareGenmab (GMAB) Health CareAlcon (ALC) Health CareArgenx (ARGX) Health CareSanofi (SNY) Health CareMerck & Co. (MRK) Health CareXencor Inc (XNCR) Health CareIllumina, Inc. (ILMN) Health Care

Filings

64 documents

Earnings releases

8 documents

Presentations

1 document

Transcripts

0 documents

No transcripts for Xenon Pharmaceuticals are held in this edition of the library.

See also the earnings calendar for every tracked company’s next earnings date.